November 4, 2025 · Form 4 insider transaction
Quigley Jill M. bought 24,520 shares of Terns Pharmaceuticals Inc at $9.24 per share, a transaction worth $226.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2024.